Analysis of differential expression of blood RNA in children with Juvenile idiopathic arthritis treated with TNF antagonists.
10.3760/cma.j.cn511374-20241222-00674
- Author:
Ping ZENG
1
,
2
;
Ying TANG
;
Feng LI
;
Huishan CHEN
;
Yanchao LI
;
Ming LIU
;
Mingqi ZHAO
;
Caihong XU
;
Wen TANG
;
Dehua XU
Author Information
1. Department of Allergy, Rheumatology and Immunology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong 510120, China. zengpingtom@
2. com.
- Publication Type:Journal Article
- MeSH:
Humans;
Arthritis, Juvenile/blood*;
Female;
Male;
Child;
Methotrexate/therapeutic use*;
Child, Preschool;
Tumor Necrosis Factor-alpha/antagonists & inhibitors*;
Transcriptome;
Adolescent;
RNA/genetics*;
Signal Transduction;
Gene Expression Profiling
- From:
Chinese Journal of Medical Genetics
2025;42(8):943-951
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To evaluate the differential expression of RNA in blood monocytes in patients with Juvenile idiopathic arthritis (JIA) treated with TNF antagonists (TNFi), and to explore the effect and mechanism of gene expression on the efficacy of JIA.
METHODS:A total of 29 children with JIA treated with methotrexate (MTX) and TNFi in Guangzhou Women and Children's Medical Center of Guangzhou Medical University from April 2021 to November 2023 were enrolled. After 6 months, the children were divided into two groups according to the treatment effect, i.e., 13 cases in the ineffective group and 16 cases in the effective group, the peripheral blood of the children was collected, the blood mononuclear cells were isolated for transcriptome sequencing, the differentially expressed genes between the groups were analyzed, the signaling pathways and metabolic pathways related to the efficacy of TNFi were analyzed by GO and KEGG enrichment, and the mechanism related to the efficacy of TNFi was explored. This study was approved by Medical Ethics Committee of the Guangzhou Women and Children's Medical Center of Guangzhou Medical University (Ethics No.: 2023-330B00).
RESULTS:There was a statistically significant difference in the gender and age distribution between the two groups of children (P < 0.05), while no statistically significant differences were observed in disease duration, rheumatoid antibody levels, or JIA subtypes (P > 0.05). After sequencing data quality control and comparison of reference genomes, a total of 18 523 protein-coding genes were identified in all children's samples. A total of 705 differentially expressed genes (DEGs) were identified between the effective group and the invalid group through differential analysis, of which 579 were up-regulated in the effective group and 126 in the inactive group. GO function and KEGG pathway enrichment analysis showed that DEG was significantly enriched in 55 GO entries and 32 KEGG metabolic pathways, which were mainly related to IL-1β production and regulation, cytokine production and regulation, cytokine-cytokine receptor interaction, immune response regulation, and Toll-like receptor signaling pathway.
CONCLUSION:DEG between the effective and ineffective groups of TNFi treatment may be involved in the biological processes such as cytokine production and regulation, cytokine-receptor interaction, and immune response regulation, which will be helpful to predict the efficacy and prognosis of TNFi treatment for JIA.
